Citation 7788

GNERRE,C: THULL,U: GAILLARD,P: CARRUPT,PA: TESTA,B: FERNANDES,E: SILVA,F: PINTO,M: PINTO,MMM: WOLFENDER,JL: HOSTETTMANN,K: CRUCIANI,G:. (2001). NATURAL AND SYNTHETIC XANTHONES AS MONOAMINE OXIDASE INHIBITORS: BIOLOGICAL ASSAY AND 3D-QSAR.. 84(3)

Citation Details

Title	NATURAL AND SYNTHETIC XANTHONES AS MONOAMINE OXIDASE INHIBITORS: BIOLOGICAL ASSAY AND 3D-QSAR.
Authors	GNERRE,C: THULL,U: GAILLARD,P: CARRUPT,PA: TESTA,B: FERNANDES,E: SILVA,F: PINTO,M: PINTO,MMM: WOLFENDER,JL: HOSTETTMANN,K: CRUCIANI,G:
Year	2001
Volume	84
Issue	3

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE	ACTIVE
2	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE	WEAK ACTIVITY
3	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-DIHYDROXY-2-METHYL:	ACTIVE
4	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-DIHYDROXY-2-METHYL:	WEAK ACTIVITY
5	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	XANTHONE,2-3-4-TRIMETHOXY:	None
6	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-3-4-TRIMETHOXY:	ACTIVE
7	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-3-4-TRIMETHOXY:	ACTIVE
8	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	XANTHONE,3-HYDROXY-4-METHOXY:	None
9	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-HYDROXY-4-METHOXY:	ACTIVE
10	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-HYDROXY-4-METHOXY:	ACTIVE
11	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	XANTHONE,4-HYDROXY-3-METHOXY:	None
12	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,4-HYDROXY-3-METHOXY:	ACTIVE
13	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,4-HYDROXY-3-METHOXY:	ACTIVE
14	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	XANTHONE,3-4-DIMETHOXY:	None
15	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-DIMETHOXY:	ACTIVE
16	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-4-DIMETHOXY:	ACTIVE
17	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	XANTHONE,3-5-DIMETHOXY:	None
18	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-5-DIMETHOXY:	ACTIVE
19	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-5-DIMETHOXY:	ACTIVE
20	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	XANTHONE,1-3-DIMETHOXY:	None
21	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-DIMETHOXY:	ACTIVE
22	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-DIMETHOXY:	ACTIVE
23	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	XANTHONE,1-HYDROXY-3-METHOXY:	None
24	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-HYDROXY-3-METHOXY:	ACTIVE
25	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-HYDROXY-3-METHOXY:	ACTIVE
26	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	XANTHONE,3-HYDROXY-5-METHOXY:	None
27	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-HYDROXY-5-METHOXY:	ACTIVE
28	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-HYDROXY-5-METHOXY:	WEAK ACTIVITY
29	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	XANTHONE,3-5-DIHYDROXY:	None
30	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-5-DIHYDROXY:	ACTIVE
31	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-5-DIHYDROXY:	WEAK ACTIVITY
32	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	XANTHONE,4-METHOXY:	None
33	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,4-METHOXY:	ACTIVE
34	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,4-METHOXY:	INACTIVE
35	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	XANTHONE,4-HYDROXY:	None
36	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,4-HYDROXY:	ACTIVE
37	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,4-HYDROXY:	WEAK ACTIVITY
38	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	XANTHONE,7-METHOXY:	None
39	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,7-METHOXY:	ACTIVE
40	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,7-METHOXY:	ACTIVE
41	Not specified	COMPLETE SYNTHESIS REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	XANTHONE,3-HYDROXY:	None
42	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-HYDROXY:	ACTIVE
43	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,3-HYDROXY:	ACTIVE
44	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	XANTHONE,2-METHOXY:	None
45	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-METHOXY:	ACTIVE
46	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-METHOXY:	ACTIVE
47	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	XANTHONE,2-HYDROXY:	None
48	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-HYDROXY:	ACTIVE
49	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,2-HYDROXY:	ACTIVE
50	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	XANTHONE,1-METHOXY:	None
51	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-METHOXY:	ACTIVE
52	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-METHOXY:	WEAK ACTIVITY
53	Not specified	COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	XANTHONE,1-HYDROXY:	None
54	MONOAMINE OXIDASE INHIBITION(TYPE A)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-HYDROXY:	ACTIVE
55	MONOAMINE OXIDASE INHIBITION(TYPE B)	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-HYDROXY:	ACTIVE

Citation 7788

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1